CDK2 inhibitors | Patent Number 11932648

US 11932648 B2
Application Number17850453
Publication NumberUS 20230159535 A1
Pendency1 year, 8 months, 26 days
Filled DateJun 27, 2022
Priority DateJun 28, 2021
Publication DateMay 25, 2023
Expiration DateJun 27, 2041
Inventor/ApplicantsNatasja Brooijmans
Joseph L. Kim
Emanuele Perola
Neil Bifulco, Jr.
Steven Mark Wenglowsky
Douglas Wilson
Richard Vargas
Philip D. Ramsden
ExaminesYOO, SUN JAE
Art Unit1621
Technology Center1600
Assignments
Blueprint Medicines Corporation
Current
Blueprint Medicines Corporation
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.